دورية أكاديمية
The molecular characterization of colistin-resistant isolates of Acinetobacter baumannii from patients at intensive care units.
العنوان: | The molecular characterization of colistin-resistant isolates of Acinetobacter baumannii from patients at intensive care units. |
---|---|
المؤلفون: | Farajnia S; Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Lotfi F; Department of Biological Sciences, Faculty of Basic Sciences, Higher Education Institute of Rab-Rashid, Tabriz, Iran., Dehnad A; Department of Biotechnology, East Azerbaijan Research and Education Center Agricultural and Natural Resources, Razi Vaccine and Serum Research Institute, AREEO, Tabriz, Iran., Shojaie M; Department of Biological Sciences, Faculty of Basic Sciences, Higher Education Institute of Rab-Rashid, Tabriz, Iran., Raisi R; Department of Biological Sciences, Faculty of Basic Sciences, Higher Education Institute of Rab-Rashid, Tabriz, Iran., Rahbarnia L; Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Bazmani A; Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Naghili B; Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Shiry S; Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. |
المصدر: | Iranian journal of microbiology [Iran J Microbiol] 2022 Jun; Vol. 14 (3), pp. 319-327. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Tehran University of Medical Sciences Country of Publication: Iran NLM ID: 101518404 Publication Model: Print Cited Medium: Print ISSN: 2008-3289 (Print) Linking ISSN: 20083289 NLM ISO Abbreviation: Iran J Microbiol Subsets: PubMed not MEDLINE |
أسماء مطبوعة: | Original Publication: Tehran : Tehran University of Medical Sciences |
مستخلص: | Background and Objectives: The objective of this study was to determine molecular characterization and genetic diversity of colistin-resistant A. baumannii clinical isolates in Intensive Care Unit hospitalized patients. Materials and Methods: A total of 127 A. baumannii clinical isolates were evaluated for antimicrobial susceptibility. PCR reaction and sequencing were performed for the detection of mutations in pmrAB and lpx ACD genes. Results: Based on antimicrobial susceptibility testing, 40.94% and 33.85% of the isolates were MDR and XDR respectively whereas 3.93% of them were found to be PDR. Results of agar dilution MIC and E-test indicated that 76% of the isolates were sensitive to colistin. All of the isolates were positive for bla Conclusion: The present study indicated the prevalence of MDR and XDR A. baumannii isolates and the emergence of PDR isolates in the northwest portion of Iran. The appearance of colistin-resistant isolates with new mutations in pmrB, lpxACD genes indicates new resistance mechanisms. (Copyright © 2022 The Authors. Published by Tehran University of Medical Sciences.) |
References: | Int J Antimicrob Agents. 2012 Jun;39(6):526-8. (PMID: 22521767) Antimicrob Resist Infect Control. 2019 Nov 7;8:172. (PMID: 31719975) Med J Islam Repub Iran. 2020 Mar 23;34:24. (PMID: 32551313) Clin Microbiol Rev. 2008 Jul;21(3):538-82. (PMID: 18625687) Antimicrob Agents Chemother. 2009 Sep;53(9):3628-34. (PMID: 19528270) Antimicrob Agents Chemother. 2010 Dec;54(12):4971-7. (PMID: 20855724) Microb Drug Resist. 2018 May;24(4):359-366. (PMID: 28972863) Front Microbiol. 2019 Jan 04;9:2898. (PMID: 30662431) Antimicrob Agents Chemother. 2011 Jul;55(7):3370-9. (PMID: 21576434) Sci Rep. 2016 Jun 22;6:28291. (PMID: 27329501) Microb Drug Resist. 2018 Jun;24(5):675-679. (PMID: 29053085) Int J Antimicrob Agents. 2011 Jun;37(6):525-30. (PMID: 21497062) Antibiotics (Basel). 2017 Nov 21;6(4):. (PMID: 29160808) Biomed Res Int. 2017;2017:7157923. (PMID: 28804720) J Microbiol. 2015 Jan;53(1):53-9. (PMID: 25557480) Microb Drug Resist. 2019 Sep;25(7):997-1002. (PMID: 30964377) Int J Antimicrob Agents. 2017 Jun;49(6):727-733. (PMID: 28438568) Clin Microbiol Infect. 2016 Apr;22(4):352-358. (PMID: 26711434) Antimicrob Agents Chemother. 2011 Jun;55(6):3022-4. (PMID: 21402838) Clin Microbiol Infect. 2012 Mar;18(3):268-81. (PMID: 21793988) J Lab Physicians. 2018 Jul-Sep;10(3):289-293. (PMID: 30078964) Expert Rev Anti Infect Ther. 2013 Apr;11(4):383-93. (PMID: 23566148) Microb Drug Resist. 2018 Nov;24(9):1271-1276. (PMID: 29590004) BMC Res Notes. 2019 May 10;12(1):260. (PMID: 31077228) Future Microbiol. 2008 Dec;3(6):649-60. (PMID: 19072182) BMC Res Notes. 2020 Aug 10;13(1):380. (PMID: 32778154) J Clin Microbiol. 2009 Feb;47(2):294-9. (PMID: 19036936) J Clin Microbiol. 2004 Mar;42(3):946-53. (PMID: 15004037) Expert Rev Anti Infect Ther. 2012 Aug;10(8):917-34. (PMID: 23030331) BMC Infect Dis. 2020 Aug 12;20(1):597. (PMID: 32787942) Expert Opin Pharmacother. 2012 Nov;13(16):2319-36. (PMID: 23035697) |
فهرسة مساهمة: | Keywords: Acinetobacter baumannii; Beta-lactamase OXA-143; Beta-lactamase OXA-23; Beta-lactamase OXA-58; Colistin; OXA-72 carbapenemase |
تواريخ الأحداث: | Date Created: 20230501 Latest Revision: 20230502 |
رمز التحديث: | 20230502 |
مُعرف محوري في PubMed: | PMC10132339 |
DOI: | 10.18502/ijm.v14i3.9768 |
PMID: | 37124847 |
قاعدة البيانات: | MEDLINE |
كن أول من يترك تعليقا!